Waist circumference is another important number to track. Larger waistlines are linked to a higher risk of heart disease, diabetes, heart attack and stroke. Belly fat indicates visceral fat, the worst ...

As a result, symptoms of a ministroke tend to be short-lived, making it easy to miss them or hand-wave them away after they let up. The problem is, the underlying trigger still exists even if your ...

1 Background Cerebral stenotic or occlusive disorders are associated with a significant decrease in flow velocity attributable to vascular stenosis or occlusion, and the development of collateral ...

The ABCD2 score (Age, Blood pressure, Clinical features, Duration of symptoms and Diabetes) is commonly used as a tool for physicians to identify people at high-risk of stroke after transient ...

An ischemic stroke is what happens when something blocks the arteries or reduces blood flow from the heart to the brain. This blockage deprives brain tissue of vital oxygen and nutrients, which ...

This retrospective study analyzed 210 cases from the Advanced Stroke Center of the Second Affiliated Hospital of Qiqihar Medical University, comparing PIS patients with general ischemic stroke ...

Article citations More>> Rothwell, P.M., Giles, M.F., Flossmann, E., et al. (2005) A Simple Clinical Score (ABCD2) to Identify Individuals at High Early Risk of Stroke after Transient Ischaemic Attack ...

Kleindorfer DO, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline from the American Heart Association/American Stroke ...

Patients were categorized into high-risk (ABCD2 score ≥4) and low-risk (ABCD2 score <4) groups. The ABCD2 score incorporates age, hypertension, clinical features, and diabetes. Long-term outcomes were ...

The purpose of this study is to examine the relationship between stroke risk stratification categories, according to ABCD2 scoring and post-ischemic stroke status, and passively- and actively ...

About this study The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke. Participation eligibility Participant eligibility includes ...